COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Modified Cervical Inversion During CS in Placenta Previa

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03772184
Recruitment Status : Completed
First Posted : December 11, 2018
Last Update Posted : October 23, 2019
Suez Canal University
Information provided by (Responsible Party):
Mahmoud Alalfy, Aljazeera Hospital

Brief Summary:
There is an increasing rates of placenta previa nowadays

Condition or disease Intervention/treatment Phase
Placenta Previa Procedure: Cervical inversion Not Applicable

Detailed Description:
several techniques were described to control bleeding .

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 240 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Using cervical inversion during cesarean section
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Alalfy Modofied Cervical Inversion During CS in Placenta Previa
Actual Study Start Date : January 10, 2019
Actual Primary Completion Date : May 12, 2019
Actual Study Completion Date : May 15, 2019

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Active Comparator: cervical inversion Procedure: Cervical inversion
inverting the cervical lip after delivery

No Intervention: no cervical inversion

Primary Outcome Measures :
  1. The number of women whose placental bed bleeding will be controlled by cervical inversion cervical inversion [ Time Frame: within an hour ]
    how can the cervical inversion technique controls the placental bed bleeding

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   20 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Gender Eligibility Description:   pregnant women with placenta previa
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • pregnant women 38 weeks with placenta previa or focal accreta

Exclusion Criteria:

  • pregnant ladies with normally implanted placenta

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03772184

Layout table for location information
Algazeerah and helwan university
Giza, Egypt
Sponsors and Collaborators
Aljazeera Hospital
Suez Canal University
Layout table for investigator information
Principal Investigator: Mahmoud Alalfy, PhD National research centre , Aljazeerah hospital
Layout table for additonal information
Responsible Party: Mahmoud Alalfy, Lecturer Obstetrics and Gyneology , National Research Centre, Aljazeera Hospital Identifier: NCT03772184    
Other Study ID Numbers: Modified cervical inversion
First Posted: December 11, 2018    Key Record Dates
Last Update Posted: October 23, 2019
Last Verified: October 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Placenta Previa
Obstetric Labor Complications
Pregnancy Complications
Placenta Diseases